P

Providence Health & Services | Providence St. Vincent Medical Center, Brain and Spine Institute

Research site

(Unclaimed)

Location

9205 SW Barnes Road, Portland, Oregon, United States of America

Site insights

Top conditions

Top treatments

Nivolumab

Pembrolizumab

Galcanezumab

Ipilimumab

Cefoxitin

Vemurafenib

Hydroxychloroquine

Cyclophosphamide

Talazoparib

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 18 total trials

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participant...

Enrolling

Chronic Migraine

Drug: Placebo

Drug: Galcanezumab

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatme...

Enrolling

Episodic Migraine

Drug: Galcanezumab

Drug: Placebo

SVC Occlusion in Subjects With Acute Decompensated Heart Failure (VENUS-HF)

Safety and performance evaluation of the preCARDIA System for patients with ADHF.

Active, not recruiting

Acute Heart Failure

Acute Decompensated Heart Failure

Device: preCARDIA system

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling

Multiple Myeloma

Advanced Solid Tumors

Drug: Trastuzumab and Pertuzumab

Drug: Palbociclib